Search Results

There are 4179 results for: content related to: Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C

  1. You have free access to this content
    Long-term therapy of chronic delta hepatitis with peginterferon alfa

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 1, July 2014, Pages: 93–104, T. Heller, Y. Rotman, C. Koh, S. Clark, V. Haynes-Williams, R. Chang, R. McBurney, P. Schmid, J. Albrecht, D. E. Kleiner, M. G. Ghany, T. J. Liang and J. H. Hoofnagle

    Version of Record online : 11 MAY 2014, DOI: 10.1111/apt.12788

  2. You have free access to this content
    UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 6, March 2012, Pages: 647–662, P. Ramachandran, A. Fraser, K. Agarwal, A. Austin, A. Brown, G. R. Foster, R. Fox, P. C. Hayes, C. Leen, P. R. Mills, D. J. Mutimer, S. D. Ryder and J. F. Dillon

    Version of Record online : 1 FEB 2012, DOI: 10.1111/j.1365-2036.2012.04992.x

  3. You have free access to this content
    Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 5, March 2014, Pages: 478–487, R. S. Koff

    Version of Record online : 6 JAN 2014, DOI: 10.1111/apt.12601

    Corrected by:

    Corrigenda: Corrigenda

    Vol. 39, Issue 8, 904, Version of Record online: 17 MAR 2014

  4. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  5. You have free access to this content
    Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk and Christian Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005642.pub3

  6. You have free access to this content
    Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 1, July 2013, Pages: 16–27, S. C. Gordon, E. M. Yoshida, E. J. Lawitz, B. R. Bacon, M. S. Sulkowski, M. Davis, F. Poordad, J.-P. Bronowicki, R. Esteban, V. Sniukiene, M. H. Burroughs, W. Deng, F. J. Dutko, C. A. Brass, J. K. Albrecht and K. Rajender Reddy

    Version of Record online : 26 MAY 2013, DOI: 10.1111/apt.12342

  7. You have free access to this content
    Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 35, Issue 4, February 2012, Pages: 458–468, C.-Y. Peng, H.-C. Lai, Y.-F. Li, W.-P. Su, P.-H. Chuang and J.-T. Kao

    Version of Record online : 8 JAN 2012, DOI: 10.1111/j.1365-2036.2011.04973.x

  8. You have free access to this content
    Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 2, July 2013, Pages: 118–123, K. Rutter, H. Hofer, S. Beinhardt, M. Dulic, M. Gschwantler, A. Maieron, H. Laferl, A. F. Stättermayer, T.-M. Scherzer, R. Strassl, H. Holzmann, P. Steindl-Munda and P. Ferenci

    Version of Record online : 26 MAY 2013, DOI: 10.1111/apt.12350

  9. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 7, October 2015, Pages: 829–844, S. Zeuzem, R. Flisiak, J. M. Vierling, W. Mazur, G. Mazzella, S. Thongsawat, D. Abdurakhmanov, N. Van Kính, P. Calistru, J. Heo, C. Stanciu, M. Gould, M. Makara, S.-J. Hsu, P. Buggisch, D. Samuel, D. Mutimer, B. Nault, M. Merz, W. Bao, L. H. Griffel, C. Brass, N. V. Naoumov and for the ESSENTIAL II Study Group

    Version of Record online : 4 AUG 2015, DOI: 10.1111/apt.13342

  10. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  11. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  12. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

    Intervention Review

    The Cochrane Library

    Alfonso Iorio, Emanuela Marchesini, Tahany Awad and Lise Lotte Gluud

    Published Online : 20 JAN 2010, DOI: 10.1002/14651858.CD004888.pub2

  13. You have free access to this content
    Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 1, January 2013, Pages: 74–80, J. A. del Campo, J. Ampuero, L. Rojas, M. Conde, Á. Rojas, M. Maraver, R. Millán, M. García-Valdecasas, J. R. García-Lozano, M. F. González-Escribano and M. Romero-Gómez

    Version of Record online : 5 NOV 2012, DOI: 10.1111/apt.12113

  14. You have free access to this content
    The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis

    HIV Medicine

    Volume 8, Issue 5, July 2007, Pages: 312–321, AI Kim, A Dorn, R Bouajram and S Saab

    Version of Record online : 7 JUN 2007, DOI: 10.1111/j.1468-1293.2007.00476.x

  15. You have free access to this content
    Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-naïve patients with chronic hepatitis C: a randomized, controlled study

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 3, August 2007, Pages: 369–376, R. BRUNO, P. SACCHI, C. SCAGNOLARI, F. TORRIANI, L. MAIOCCHI, S. PATRUNO, F. BELLOMI, G. FILICE and G. ANTONELLI

    Version of Record online : 29 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03392.x

  16. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients

    Intervention Review

    The Cochrane Library

    Lior H Katz, Hadar Goldvaser, Anat Gafter-Gvili and Ran Tur-Kaspa

    Published Online : 12 SEP 2012, DOI: 10.1002/14651858.CD008516.pub2

  17. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046

  18. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  19. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 14, Issue 10, October 2007, Pages: 721–729, A. M. Di Bisceglie, R. H. Ghalib, F. M. Hamzeh and V. K. Rustgi

    Version of Record online : 26 APR 2007, DOI: 10.1111/j.1365-2893.2007.00862.x

  20. Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 7, April 2015, Pages: 671–685, R. K. Sterling, A. Kuo, V. K. Rustgi, M. S. Sulkowski, T. G. Stewart, J. M. Fenkel, H. El-Genaidi, M. A. Mah'moud, G. M. Abraham, P. W. Stewart, L. Akushevich, D. R. Nelson, M. W. Fried and A. M. Di Bisceglie

    Version of Record online : 28 JAN 2015, DOI: 10.1111/apt.13095